Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization

AIDS Research and Human Retroviruses

Volumn 12, Issue 4, 1996, Pages 259-272

  Ahlers, J D ^a   Dunlop, N ^a   Pendleton, C D ^a   Newman, M ^a   Nara, P L ^a   Berzofsky, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALHYDROGEL SUPERFOS; ALUMINUM HYDROXIDE; FREUND ADJUVANT; GLYCOPROTEIN GP 160; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; MONTANIDE ISA 51; N [1 (2,3 DIOLEOYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM IODIDE; N [1 (2,3 DIOLEOYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM METHYLSULFATE; NEUTRALIZING ANTIBODY; QS 21; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG CROSS REACTIVITY; DRUG FORMULATION; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029975955     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.259     Document Type: Article

References (0)